Beyond Air, Inc. (XAIR) IPO - S-1 Filing, Stock & Insider Activity
Beyond Air, Inc. IPO - Status & S-1 Filing
- Ticker: XAIR
- Status: Registered - S-1 filed with the SEC
- S-1 filed: 2025-11-21
- Expected price range: not yet disclosed (set in a later S-1/A or pricing amendment)
- SEC CIK: 0001641631 · View the S-1 on SEC EDGAR →
Track every registration update on the InsiderAlpha IPO tracker.
Last SEC filing
Beyond Air, Inc. (XAIR) has filed 2 SEC Form 4 insider transactions in the last 90 days, with the most recent on 2026-07-31. Insiders disclosed 6 open-market purchases totaling $225K. 22 Form 8-K material event filings were reported by XAIR in the last 90 days. InsiderAlpha tracks every XAIR SEC filing - Form 4, Form 144, and 8-K - in real time, including Rule 10b5-1 plan detection.
About Beyond Air, Inc. (XAIR)
Beyond Air, Inc. trades under the ticker XAIR. InsiderAlpha tracks 23 primary SEC Form 4 filings from 10 reporting insiders for XAIR since 2024, sourced directly from SEC EDGAR.
| Sector | Health Care insider trading |
|---|---|
| SIC classification | Surgical & Medical Instruments & Apparatus (SIC 3841) |
| SEC CIK | 0001641631 |
90-Day SEC Filing Activity
| Insider purchases (90d) | 6 ($225K) |
|---|---|
| Form 4 filings (90d) | 2 |
| Form 8-K filings (90d) | 22 |
| Latest Form 4 filing | 2026-07-31 |
Recent XAIR Insider Transactions (Form 4)
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Daniel J. Moorhead | Chief Financial Officer | P - Open-market purchase | 4.3K | $5.76 | $25K | SEC | |
| Robert Scott Goodman | Chief Executive Officer | P - Open-market purchase | 34.7K | $5.76 | $200K | SEC | |
| Steven A. Lisi | CEO and Chairman of the Board | P - Open-market purchase | 6.0K | $3.25 | $19K | SEC | |
| Robert Carey | Director | P - Open-market purchase | 1.48M | $0.50 | $745K | SEC | |
| Steven A. Lisi | CEO and Chairman of the Board | P - Open-market purchase | 1.48M | $0.50 | $745K | SEC |
All transactions sourced from SEC EDGAR Form 4 filings for Beyond Air, Inc. (XAIR). Updated in real time as new filings are submitted to the SEC.
Most-Active XAIR Insiders - Last 90 Days
| Insider | Form 4 filings | Total transaction value |
|---|---|---|
| Robert Scott Goodman | 3 | $200K |
| Daniel J. Moorhead | 3 | $25K |
Recent XAIR Form 8-K Material Events
- - Item 1.01, 3.02, 8.01, 9.01 [SEC]
- - Other · neutral [SEC]
Trading halt (T3) for XAIR. XAIR - - Other · neutral [SEC]
Trading halt (T3) for XAIR. XAIR - - Other · neutral [SEC]
Trading halt (T3) for XAIR. XAIR - - Other · neutral [SEC]
Trading halt (T3) for XAIR. XAIR
Recent Insider Filings
- - Robert Scott Goodman (Chief Executive Officer)
- - Daniel J. Moorhead (Chief Financial Officer)
- - Daniel J. Moorhead (Chief Financial Officer)
- - Michael A. Gaul (Chief Operating Officer)
- - Yoori Lee (Director)
Form 4 Transaction Code Reference
SEC Form 4 transactions are reported with a one-letter code indicating the type of transaction. Common codes you'll see in XAIR insider filings:
| P | Open-market purchase by the insider |
|---|---|
| S | Open-market sale by the insider |
| A | Grant, award, or other acquisition from the issuer |
| M | Exercise or conversion of derivative security (e.g. options) |
| F | Payment of exercise price or tax liability via share withholding |
| G | Bona-fide gift of securities |
| D | Disposition to the issuer (e.g. share buyback participation) |
| J | Other acquisition or disposition |
| X | Exercise of in-the-money or at-the-money derivative security |
| C | Conversion of derivative security |
| V | Transaction voluntarily reported earlier than required |
XAIR Insider Trading - FAQ
- What is the latest insider trade for XAIR?
- Beyond Air, Inc. (XAIR) had 2 insider filings in the last 90 days, with the most recent on 2026-07-31. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
- How many insiders are buying XAIR stock?
- 6 insider purchases of XAIR were filed in the last 90 days, totaling $225K.
- How many insiders are selling XAIR stock?
- 0 insider sales of XAIR were filed in the last 90 days.
- Where can I see XAIR SEC filings (Form 4, 10-K, 10-Q, 8-K)?
- This page tracks XAIR Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care Companies with Insider Activity
Other companies in the InsiderAlpha index with a significant SEC Form 4 insider-trading footprint:
- $ZBIO Zenas BioPharma, Inc.
- $ZURA Zura Bio Ltd
- $ZYME Zymeworks Inc.
- $ABP Abpro Holdings, Inc.
- $AEMD AETHLON MEDICAL INC
- $AHCO AdaptHealth Corp.
- $AIM AIM ImmunoTech Inc.
- $AKTX Akari Therapeutics Plc
- $ALMS ALUMIS INC.
- $ANNX Annexon, Inc.
Related Companies - Recent Insider Activity
- DEXCOM INC (DXCM)
- TANDEM DIABETES CARE INC (TNDM)
- GLAUKOS Corp (GKOS)
- Heartflow, Inc. (HTFL)
- ANGIODYNAMICS INC (ANGO)
- ClearPoint Neuro, Inc. (CLPT)
- NovoCure Ltd (NVCR)
- AtriCure, Inc. (ATRC)
- Solventum Corp (SOLV)
- MERIT MEDICAL SYSTEMS INC (MMSI)
Learn More
- What is SEC Form 4?
- How to read insider buying signals
- Rule 10b5-1 trading plans explained
- The cluster buying signal
Open the live XAIR dashboard on InsiderAlpha for real-time alerts, charting, and full historical filing search.